Symbols / EOLS
EOLS Chart
About
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Drug Manufacturers - Spe | Market Cap | 283.26M |
| Enterprise Value | 390.09M | Income | -58.56M | Sales | 285.82M |
| Book/sh | -0.44 | Cash/sh | 0.67 | Dividend Yield | — |
| Payout | 0.00% | Employees | 329 | IPO | — |
| P/E | — | Forward P/E | -67.23 | PEG | — |
| P/S | 0.99 | P/B | -9.84 | P/C | — |
| EV/EBITDA | -12.41 | EV/Sales | 1.36 | Quick Ratio | 1.41 |
| Current Ratio | 2.02 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -0.90 | EPS next Y | -0.07 | EPS Growth | — |
| Revenue Growth | 12.90% | Earnings | 2026-03-03 | ROA | -10.60% |
| ROE | — | ROIC | — | Gross Margin | 66.63% |
| Oper. Margin | -14.74% | Profit Margin | -20.49% | Shs Outstand | 64.82M |
| Shs Float | 49.15M | Short Float | 11.64% | Short Ratio | 5.06 |
| Short Interest | — | 52W High | 14.94 | 52W Low | 4.09 |
| Beta | 1.01 | Avg Volume | 1.08M | Volume | 48.19K |
| Target Price | $15.17 | Recom | None | Prev Close | $4.30 |
| Price | $4.37 | Change | 1.63% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$15.17
Mean price target
2. Current target
$4.37
Latest analyst target
3. DCF / Fair value
$-9.57
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$4.37
Low
$10.00
High
$20.00
Mean
$15.17
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-02-03 | main | HC Wainwright & Co. | Buy → Buy | $13 |
| 2026-01-22 | main | BTIG | Buy → Buy | $13 |
| 2026-01-13 | main | Stifel | Buy → Buy | $17 |
| 2026-01-09 | reit | HC Wainwright & Co. | Buy → Buy | $20 |
| 2025-12-24 | reit | Needham | Hold → Hold | — |
| 2025-12-02 | main | Mizuho | Outperform → Outperform | $19 |
| 2025-09-08 | reit | BTIG | Buy → Buy | $18 |
| 2025-08-06 | main | BTIG | Buy → Buy | $18 |
| 2025-08-06 | down | Needham | Buy → Hold | $22 |
| 2025-08-06 | main | HC Wainwright & Co. | Buy → Buy | $20 |
| 2025-05-08 | reit | Needham | Buy → Buy | $22 |
| 2025-04-17 | init | BTIG | — → Buy | $21 |
| 2025-04-10 | reit | HC Wainwright & Co. | Buy → Buy | $27 |
| 2025-04-09 | reit | Needham | Buy → Buy | $22 |
| 2025-03-05 | main | Barclays | Overweight → Overweight | $25 |
| 2025-03-05 | reit | HC Wainwright & Co. | Buy → Buy | $27 |
| 2025-03-05 | reit | Needham | Buy → Buy | $22 |
| 2025-02-14 | reit | HC Wainwright & Co. | Buy → Buy | $27 |
| 2025-01-27 | main | Barclays | Overweight → Overweight | $22 |
| 2025-01-22 | reit | HC Wainwright & Co. | Buy → Buy | $27 |
- Beauty firm Evolus to field investor questions at Miami healthcare event - Stock Titan Wed, 25 Feb 2026 13
- Evolus, Inc. (EOLS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Finviz ue, 24 Feb 2026 16
- Evolus, Inc. (EOLS) Stock Analysis: A Potential 243% Upside Ignites Investor Interest - DirectorsTalk Interviews Sat, 21 Feb 2026 05
- Evolus, Inc. (EOLS) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance Wed, 05 Nov 2025 08
- $EOLS stock is down 12% today. Here's what we see in our data. | EOLS Stock News - Quiver Quantitative Wed, 14 Jan 2026 08
- How Low Can Evolus Stock Really Go? - Trefis hu, 18 Dec 2025 08
- Evolus stock down on Q2 miss; Needham downgrades (EOLS:NASDAQ) - Seeking Alpha Wed, 06 Aug 2025 07
- Evolus, Inc. (NASDAQ:EOLS): When Will It Breakeven? - simplywall.st ue, 16 Sep 2025 07
- Beauty brand Evolus will detail 2025 results on March 3 call - Stock Titan ue, 17 Feb 2026 13
- Mizuho Lowers Price Target on Evolus, Inc. (EOLS) to $15, Maintains Outperform Rating - Yahoo Finance Mon, 09 Feb 2026 08
- Evolus, Inc. (EOLS) Stock Analysis: Is A 179% Potential Upside Worth The Risk? - DirectorsTalk Interviews Fri, 24 Oct 2025 07
- Evolus: A Difficult 2025 Means I'm Downgrading Stock To 'Hold' For 2026 (NASDAQ:EOLS) - Seeking Alpha Wed, 17 Dec 2025 08
- Insider Sale: See Remarks of $EOLS Sells 10,539 Shares - Quiver Quantitative Mon, 29 Dec 2025 08
- Despite shrinking by US$49m in the past week, Evolus (NASDAQ:EOLS) shareholders are still up 92% over 5 years - simplywall.st Mon, 03 Nov 2025 08
- What Catalysts Are Rewriting The Evolus (EOLS) Story After The Guidance Reset - Yahoo Finance ue, 10 Feb 2026 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 45559 | — | — | Stock Award(Grant) at price 0.00 per share. | PARSCHAUER KARAH HERDMAN | Director | — | 2026-02-17 00:00:00 | D |
| 1 | 313212 | — | — | Stock Award(Grant) at price 0.00 per share. | MOATAZEDI DAVID | Chief Executive Officer | — | 2026-02-17 00:00:00 | D |
| 2 | 45559 | — | — | Stock Award(Grant) at price 0.00 per share. | MALIK VIKRAM | Director | — | 2026-02-17 00:00:00 | D |
| 3 | 45559 | — | — | Stock Award(Grant) at price 0.00 per share. | STEWART BRADY | Director | — | 2026-02-17 00:00:00 | D |
| 4 | 121489 | — | — | Stock Award(Grant) at price 0.00 per share. | MITCHELL TATJANA | Chief Financial Officer | — | 2026-02-17 00:00:00 | D |
| 5 | 2261 | 16168 | — | Sale at price 7.15 per share. | AVELAR RUI L. | Officer | — | 2025-12-22 00:00:00 | D |
| 6 | 10539 | 75361 | — | Sale at price 7.15 per share. | MOATAZEDI DAVID | Chief Executive Officer | — | 2025-12-22 00:00:00 | D |
| 7 | 104603 | — | — | Stock Award(Grant) at price 0.00 per share. | MITCHELL TATJANA | Chief Financial Officer | — | 2025-09-08 00:00:00 | D |
| 8 | 5722 | 42972 | — | Sale at price 7.51 per share. | YAMAGISHI-DRESSLER TOMOKO | Officer | — | 2025-08-22 00:00:00 | D |
| 9 | 30000 | 204486 | — | Purchase at price 6.82 per share. | STEWART BRADY | Director | — | 2025-08-15 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 6.62M |
| TaxRateForCalcs | 0.21 | 0.21 | 0.21 | 0.27 |
| NormalizedEBITDA | -25.00M | -41.81M | -60.72M | -63.59M |
| TotalUnusualItems | 0.00 | 24.53M | ||
| TotalUnusualItemsExcludingGoodwill | 0.00 | 24.53M | ||
| NetIncomeFromContinuingOperationNetMinorityInterest | -50.42M | -61.69M | -74.41M | -46.81M |
| ReconciledDepreciation | 6.02M | 5.87M | 4.50M | 6.31M |
| ReconciledCostOfRevenue | 80.29M | 60.83M | 55.11M | 42.84M |
| EBITDA | -25.00M | -41.81M | -60.72M | -39.06M |
| EBIT | -31.02M | -47.68M | -65.22M | -45.37M |
| NetInterestIncome | -15.47M | -12.97M | -8.98M | -1.40M |
| InterestExpense | 18.73M | 13.83M | 9.10M | 1.40M |
| InterestIncome | 3.26M | 860.00K | 119.00K | 1.00K |
| NormalizedIncome | -50.42M | -61.69M | -74.41M | -64.72M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -50.42M | -61.69M | -74.41M | -46.81M |
| TotalExpenses | 293.51M | 247.06M | 208.19M | 163.29M |
| TotalOperatingIncomeAsReported | -34.41M | -49.23M | -65.33M | -44.41M |
| DilutedAverageShares | 62.25M | 56.92M | 56.06M | 49.77M |
| BasicAverageShares | 62.25M | 56.92M | 56.06M | 49.77M |
| DilutedEPS | -0.81 | -1.08 | -1.33 | -0.94 |
| BasicEPS | -0.81 | -1.08 | -1.33 | -0.94 |
| DilutedNIAvailtoComStockholders | -50.42M | -61.69M | -74.41M | -46.81M |
| NetIncomeCommonStockholders | -50.42M | -61.69M | -74.41M | -46.81M |
| NetIncome | -50.42M | -61.69M | -74.41M | -46.81M |
| NetIncomeIncludingNoncontrollingInterests | -50.42M | -61.69M | -74.41M | -46.81M |
| NetIncomeContinuousOperations | -50.42M | -61.69M | -74.41M | -46.81M |
| TaxProvision | 664.00K | 176.00K | 95.00K | 42.00K |
| PretaxIncome | -49.76M | -61.51M | -74.32M | -46.77M |
| OtherIncomeExpense | -7.05M | -3.56M | -5.76M | 18.24M |
| OtherNonOperatingIncomeExpenses | -7.05M | -3.56M | -5.76M | -6.29M |
| SpecialIncomeCharges | 0.00 | 24.53M | ||
| OtherSpecialCharges | 2.00M | -24.53M | ||
| RestructuringAndMergernAcquisition | 0.00 | |||
| NetNonOperatingInterestIncomeExpense | -15.47M | -12.97M | -8.98M | -1.40M |
| InterestExpenseNonOperating | 18.73M | 13.83M | 9.10M | 1.40M |
| InterestIncomeNonOperating | 3.26M | 860.00K | 119.00K | 1.00K |
| OperatingIncome | -27.23M | -44.98M | -59.58M | -63.62M |
| OperatingExpense | 209.54M | 182.55M | 149.35M | 119.75M |
| DepreciationAmortizationDepletionIncomeStatement | 2.34M | 2.18M | 767.00K | 5.62M |
| DepreciationAndAmortizationInIncomeStatement | 2.34M | 2.18M | 767.00K | 5.62M |
| ResearchAndDevelopment | 9.17M | 15.43M | 6.74M | 2.06M |
| SellingGeneralAndAdministration | 198.03M | 164.94M | 141.84M | 112.07M |
| GrossProfit | 182.30M | 137.57M | 89.77M | 56.14M |
| CostOfRevenue | 83.97M | 64.51M | 58.84M | 43.53M |
| TotalRevenue | 266.27M | 202.09M | 148.62M | 99.67M |
| OperatingRevenue | 266.27M | 202.09M | 148.62M | 99.67M |
| Line Item | 2023-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 63.50M | 57.82M | 56.26M | 55.58M |
| ShareIssued | 63.50M | 57.82M | 56.26M | 55.58M |
| NetDebt | 34.55M | 57.52M | 17.96M | |
| TotalDebt | 129.98M | 126.55M | 74.42M | 74.74M |
| TangibleBookValue | -64.44M | -89.01M | -51.31M | 10.04M |
| InvestedCapital | 127.03M | 99.67M | 90.38M | 153.10M |
| WorkingCapital | 88.38M | 64.13M | 54.29M | 121.14M |
| NetTangibleAssets | -64.44M | -89.01M | -51.31M | 10.04M |
| CapitalLeaseObligations | 8.47M | 6.19M | 2.54M | 3.52M |
| CommonStockEquity | 5.52M | -20.69M | 18.50M | 81.88M |
| TotalCapitalization | 127.03M | 99.67M | 90.38M | 153.10M |
| TotalEquityGrossMinorityInterest | 5.52M | -20.69M | 18.50M | 81.88M |
| StockholdersEquity | 5.52M | -20.69M | 18.50M | 81.88M |
| GainsLossesNotAffectingRetainedEarnings | -905.00K | -427.00K | -337.00K | 0.00 |
| OtherEquityAdjustments | -905.00K | -427.00K | -337.00K | |
| RetainedEarnings | -609.40M | -558.98M | -497.29M | -422.88M |
| AdditionalPaidInCapital | 615.83M | 538.72M | 516.13M | 504.76M |
| CapitalStock | 1.00K | 1.00K | 1.00K | 1.00K |
| CommonStock | 1.00K | 1.00K | 1.00K | 1.00K |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 227.05M | 209.69M | 159.48M | 175.61M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 164.09M | 161.40M | 112.97M | 117.94M |
| NonCurrentAccruedExpenses | 0.00 | 5.00M | ||
| DuetoRelatedPartiesNonCurrent | 33.55M | 36.20M | 39.85M | 39.43M |
| TradeandOtherPayablesNonCurrent | 2.27M | 0.00 | 0.00 | 0.00 |
| NonCurrentDeferredLiabilities | 6.00K | 27.00K | 22.00K | 40.00K |
| NonCurrentDeferredTaxesLiabilities | 6.00K | 27.00K | 22.00K | 40.00K |
| LongTermDebtAndCapitalLeaseObligation | 128.26M | 125.17M | 73.10M | 73.48M |
| LongTermCapitalLeaseObligation | 6.75M | 4.81M | 1.22M | 2.26M |
| LongTermDebt | 121.51M | 120.36M | 71.88M | 71.22M |
| CurrentLiabilities | 62.96M | 48.29M | 46.51M | 57.66M |
| CurrentDeferredLiabilities | 14.45M | 11.03M | 9.01M | 7.93M |
| CurrentDeferredRevenue | 14.45M | 11.03M | 9.01M | 7.93M |
| CurrentDebtAndCapitalLeaseObligation | 1.72M | 1.38M | 1.32M | 1.26M |
| CurrentCapitalLeaseObligation | 1.72M | 1.38M | 1.32M | 1.26M |
| CurrentNotesPayable | 0.00 | |||
| PensionandOtherPostRetirementBenefitPlansCurrent | 6.86M | |||
| PayablesAndAccruedExpenses | 46.79M | 35.88M | 36.18M | 48.46M |
| CurrentAccruedExpenses | 26.34M | 22.78M | 20.78M | 37.06M |
| Payables | 20.45M | 13.10M | 15.39M | 11.40M |
| DuetoRelatedPartiesCurrent | 11.21M | 8.83M | 6.46M | 5.31M |
| AccountsPayable | 9.24M | 4.27M | 8.94M | 6.09M |
| TotalAssets | 232.57M | 189.00M | 177.98M | 257.48M |
| TotalNonCurrentAssets | 81.23M | 76.58M | 77.18M | 78.68M |
| OtherNonCurrentAssets | 858.00K | 409.00K | 2.81M | 2.76M |
| GoodwillAndOtherIntangibleAssets | 69.96M | 68.32M | 69.81M | 71.83M |
| OtherIntangibleAssets | 48.75M | 47.11M | 48.60M | 50.62M |
| Goodwill | 21.21M | 21.21M | 21.21M | 21.21M |
| NetPPE | 10.41M | 7.85M | 4.56M | 4.09M |
| AccumulatedDepreciation | -3.52M | -2.40M | ||
| GrossPPE | 13.93M | 10.25M | 4.56M | 4.09M |
| Leases | 3.57M | 2.21M | ||
| OtherProperties | 7.64M | 5.84M | 4.56M | 4.09M |
| MachineryFurnitureEquipment | 2.72M | 2.19M | ||
| Properties | 0.00 | 0.00 | ||
| CurrentAssets | 151.34M | 112.42M | 100.80M | 178.80M |
| OtherCurrentAssets | 1.20M | 2.36M | 1.68M | 11.04M |
| PrepaidAssets | 3.35M | 5.70M | 3.90M | 5.08M |
| Inventory | 12.16M | 11.00M | 18.85M | 1.76M |
| Receivables | 47.68M | 30.53M | 22.45M | 14.66M |
| AccountsReceivable | 47.68M | 30.53M | 22.45M | 14.66M |
| AllowanceForDoubtfulAccountsReceivable | -2.71M | -1.49M | -2.05M | -2.38M |
| GrossAccountsReceivable | 50.40M | 32.02M | 24.50M | 17.04M |
| CashCashEquivalentsAndShortTermInvestments | 86.95M | 62.84M | 53.92M | 146.26M |
| OtherShortTermInvestments | 0.00 | |||
| CashAndCashEquivalents | 86.95M | 62.84M | 53.92M | 146.26M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -22.82M | -35.63M | -87.85M | -34.36M |
| RepaymentOfDebt | 0.00 | -96.32M | ||
| IssuanceOfDebt | 0.00 | 50.00M | 0.00 | 71.96M |
| IssuanceOfCapitalStock | 51.21M | 0.00 | 0.00 | 103.34M |
| CapitalExpenditure | -4.82M | -1.63M | -2.94M | -970.00K |
| InterestPaidSupplementalData | 17.55M | 12.71M | 8.00M | 138.00K |
| IncomeTaxPaidSupplementalData | 235.00K | 117.00K | 76.00K | 14.00K |
| EndCashPosition | 86.95M | 62.84M | 53.92M | 146.26M |
| BeginningCashPosition | 62.84M | 53.92M | 146.26M | 102.56M |
| EffectOfExchangeRateChanges | -478.00K | -90.00K | -337.00K | 0.00 |
| ChangesInCash | 24.59M | 9.01M | -92.00M | 43.69M |
| FinancingCashFlow | 47.41M | 44.64M | -4.15M | 73.05M |
| CashFlowFromContinuingFinancingActivities | 47.41M | 44.64M | -4.15M | 73.05M |
| NetOtherFinancingCharges | -8.68M | -5.59M | -4.68M | -6.57M |
| ProceedsFromStockOptionExercised | 4.88M | 231.00K | 539.00K | 655.00K |
| NetCommonStockIssuance | 51.21M | 0.00 | 0.00 | 103.34M |
| CommonStockIssuance | 51.21M | 0.00 | 0.00 | 103.34M |
| NetIssuancePaymentsOfDebt | 0.00 | 50.00M | 0.00 | -24.36M |
| NetLongTermDebtIssuance | 0.00 | 50.00M | 0.00 | -24.36M |
| LongTermDebtPayments | 0.00 | -96.32M | ||
| LongTermDebtIssuance | 0.00 | 50.00M | 0.00 | 71.96M |
| InvestingCashFlow | -4.82M | -1.63M | -2.94M | 4.03M |
| CashFlowFromContinuingInvestingActivities | -4.82M | -1.63M | -2.94M | 4.03M |
| NetInvestmentPurchaseAndSale | 0.00 | 5.00M | ||
| SaleOfInvestment | 0.00 | 5.00M | ||
| PurchaseOfInvestment | 0.00 | |||
| NetPPEPurchaseAndSale | -1.47M | -473.00K | -1.62M | -393.00K |
| PurchaseOfPPE | -1.47M | -473.00K | -1.62M | -393.00K |
| CapitalExpenditureReported | -3.35M | -1.15M | -1.32M | -577.00K |
| OperatingCashFlow | -18.00M | -34.01M | -84.91M | -33.39M |
| CashFlowFromContinuingOperatingActivities | -18.00M | -34.01M | -84.91M | -33.39M |
| ChangeInWorkingCapital | -6.60M | -5.89M | -34.25M | -11.54M |
| ChangeInOtherCurrentLiabilities | -716.00K | -907.00K | -977.00K | -838.00K |
| ChangeInOtherCurrentAssets | 706.00K | -864.00K | 4.85M | -7.01M |
| ChangeInPayablesAndAccruedExpense | 7.41M | 3.00M | -19.23M | 5.10M |
| ChangeInAccruedExpense | 7.01M | 4.02M | -20.20M | 5.89M |
| ChangeInPayable | 391.00K | -1.02M | 968.00K | -787.00K |
| ChangeInAccountPayable | 391.00K | -1.02M | 968.00K | -787.00K |
| ChangeInPrepaidAssets | 2.35M | -1.80M | 1.18M | -254.00K |
| ChangeInInventory | 3.25M | 4.19M | -10.69M | -2.98M |
| ChangeInReceivables | -19.60M | -9.52M | -9.39M | -5.57M |
| ChangesInAccountReceivables | -19.60M | -9.52M | -9.39M | -5.57M |
| OtherNonCashItems | 8.32M | 9.80M | 6.84M | 7.23M |
| StockBasedCompensation | 22.25M | 16.46M | 10.83M | 9.58M |
| ProvisionandWriteOffofAssets | 2.45M | 1.44M | 1.60M | 589.00K |
| AmortizationOfSecurities | 0.00 | 272.00K | ||
| DeferredTax | -21.00K | 5.00K | -18.00K | 15.00K |
| DeferredIncomeTax | -21.00K | 5.00K | -18.00K | 15.00K |
| DepreciationAmortizationDepletion | 6.02M | 5.87M | 4.50M | 6.31M |
| DepreciationAndAmortization | 6.02M | 5.87M | 4.50M | 6.31M |
| Depreciation | 6.02M | 5.87M | 4.50M | 6.31M |
| OperatingGainsLosses | 968.00K | |||
| NetIncomeFromContinuingOperations | -50.42M | -61.69M | -74.41M | -46.81M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for EOLS
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|